• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于分子动力学模拟研究罗斯考维汀和靛玉红-3'-肟对细胞周期蛋白依赖性激酶的抑制作用

Study of the inhibition of cyclin-dependent kinases with roscovitine and indirubin-3'-oxime from molecular dynamics simulations.

作者信息

Zhang Bing, Tan Vincent B C, Lim Kian Meng, Tay Tong Earn, Zhuang Shulin

机构信息

Nanoscience and Nanotechnology Initiative, National University of Singapore, 2 Engineering Drive 3, Singapore, 117576, Singapore.

出版信息

J Mol Model. 2007 Jan;13(1):79-89. doi: 10.1007/s00894-006-0127-x. Epub 2006 Jun 13.

DOI:10.1007/s00894-006-0127-x
PMID:16770643
Abstract

Molecular dynamics simulations were performed to elucidate the interactions of CDK2 and CDK5 complexes with three inhibitors: R-roscovitine, S-roscovitine, and indirubin-3'-oxime. The preference of the two complexes for R-roscovitine over the S enantiomer, as reported by the experiment, was also found by the simulations. More importantly, the simulations showed that the cause of the stronger affinity for the R enantiomer is the presence of an important hydrogen bond between R-roscovitine and the kinases not found with S-roscovitine. The simulations also showed two amino acid mutations in the active site of CDK5/R-roscovitine that favor binding-enhanced electrostatic contributions, making the inhibitor more effective for CDK5 than for CDK2. This suggests that the effectiveness of roscovitine-like inhibitors can be improved by enhancing their electrostatic interaction with the kinases. Finally, molecular mechanics-Possion-Boltzmann/surface area calculations of the CDK5/indirubin-3'-oxime system in both water-excluded and water-included environments gave significantly different electrostatic contributions to the binding. The simulations detected the displacement of a water molecule in the active site of the water-included CDK/indirubin-3'-oxime system. This resulted in a more conserved binding pattern than the water-excluded structure. Hence, in the design of new indirubin-like inhibitors, it is important to include the water molecule in the analysis.

摘要

进行了分子动力学模拟,以阐明细胞周期蛋白依赖性激酶2(CDK2)和细胞周期蛋白依赖性激酶5(CDK5)复合物与三种抑制剂:R-罗斯考维汀、S-罗斯考维汀和靛玉红-3'-肟的相互作用。模拟结果也发现了这两种复合物对R-罗斯考维汀的偏好高于S对映体,这与实验报道一致。更重要的是,模拟结果表明,对R对映体具有更强亲和力的原因是R-罗斯考维汀与激酶之间存在重要的氢键,而S-罗斯考维汀没有这种氢键。模拟还显示,CDK5/R-罗斯考维汀活性位点存在两个氨基酸突变,有利于增强结合的静电作用,使得该抑制剂对CDK5比对CDK2更有效。这表明,通过增强与激酶的静电相互作用,可以提高罗斯考维汀样抑制剂的有效性。最后,在无水和有水环境下对CDK5/靛玉红-3'-肟系统进行分子力学-泊松-玻尔兹曼/表面积计算,得到的结合静电贡献显著不同。模拟检测到有水的CDK/靛玉红-3'-肟系统活性位点中一个水分子的位移。这导致了比无水结构更保守的结合模式。因此,在设计新的靛玉红样抑制剂时,在分析中考虑水分子很重要。

相似文献

1
Study of the inhibition of cyclin-dependent kinases with roscovitine and indirubin-3'-oxime from molecular dynamics simulations.基于分子动力学模拟研究罗斯考维汀和靛玉红-3'-肟对细胞周期蛋白依赖性激酶的抑制作用
J Mol Model. 2007 Jan;13(1):79-89. doi: 10.1007/s00894-006-0127-x. Epub 2006 Jun 13.
2
Binding mechanism of CDK5 with roscovitine derivatives based on molecular dynamics simulations and MM/PBSA methods.基于分子动力学模拟和MM/PBSA方法的CDK5与罗司维汀衍生物的结合机制
J Mol Graph Model. 2016 Jul;68:57-67. doi: 10.1016/j.jmgm.2016.06.007. Epub 2016 Jun 16.
3
Mechanism of CDK5/p25 binding by CDK inhibitors.CDK抑制剂与CDK5/p25结合的机制。
J Med Chem. 2005 Feb 10;48(3):671-9. doi: 10.1021/jm049323m.
4
Dynamics and binding modes of free cdk2 and its two complexes with inhibitors studied by computer simulations.通过计算机模拟研究游离的细胞周期蛋白依赖性激酶2(cdk2)及其与抑制剂的两种复合物的动力学和结合模式。
J Biomol Struct Dyn. 2002 Oct;20(2):141-54. doi: 10.1080/07391102.2002.10506830.
5
Different mechanisms of CDK5 and CDK2 activation as revealed by CDK5/p25 and CDK2/cyclin A dynamics.CDK5/p25和CDK2/细胞周期蛋白A动力学揭示的CDK5和CDK2激活的不同机制
J Biol Chem. 2006 Mar 17;281(11):7271-81. doi: 10.1074/jbc.M509699200. Epub 2006 Jan 9.
6
Molecular model of cyclin-dependent kinase 5 complexed with roscovitine.与罗可维汀复合的细胞周期蛋白依赖性激酶5的分子模型。
Biochem Biophys Res Commun. 2002 Oct 11;297(5):1154-8. doi: 10.1016/s0006-291x(02)02352-5.
7
Analysis of CDK2 active-site hydration: a method to design new inhibitors.细胞周期蛋白依赖性激酶2(CDK2)活性位点水化分析:一种设计新型抑制剂的方法。
Proteins. 2004 May 1;55(2):258-74. doi: 10.1002/prot.20026.
8
An evaluation of indirubin analogues as phosphorylase kinase inhibitors.靛玉红类似物作为磷酸化酶激酶抑制剂的评估。
J Mol Graph Model. 2015 Sep;61:231-42. doi: 10.1016/j.jmgm.2015.07.010. Epub 2015 Aug 3.
9
Significance of water molecules in the inhibition of cylin-dependent kinase 2 and 5 complexes.
J Chem Inf Model. 2007 Sep-Oct;47(5):1877-85. doi: 10.1021/ci700137c. Epub 2007 Aug 22.
10
Molecular models of cyclin-dependent kinase 1 complexed with inhibitors.与抑制剂复合的细胞周期蛋白依赖性激酶1的分子模型。
Biochem Biophys Res Commun. 2004 Nov 12;324(2):661-6. doi: 10.1016/j.bbrc.2004.09.109.

引用本文的文献

1
Cyclin-dependent Kinase 5 and Neurodegenerative Diseases.细胞周期蛋白依赖性激酶 5 与神经退行性疾病。
Mol Neurobiol. 2024 Oct;61(10):7287-7302. doi: 10.1007/s12035-024-04047-1. Epub 2024 Feb 20.
2
Analysis of the Inhibitory Elements in the p5 Peptide Fragment of the CDK5 Activator, p35, CDKR1 Protein.细胞周期蛋白依赖性激酶5激活剂p35的p5肽片段、CDKR1蛋白中抑制元件的分析
J Alzheimers Dis. 2015;48(4):1009-17. doi: 10.3233/JAD-150412.
3
Investigation of the flexibility of protein kinases implicated in the pathology of Alzheimer's disease.

本文引用的文献

1
From the insoluble dye indirubin towards highly active, soluble CDK2-inhibitors.
Chembiochem. 2005 Mar;6(3):531-40. doi: 10.1002/cbic.200400108.
2
Mechanism of CDK5/p25 binding by CDK inhibitors.CDK抑制剂与CDK5/p25结合的机制。
J Med Chem. 2005 Feb 10;48(3):671-9. doi: 10.1021/jm049323m.
3
The mechanism of inhibition of the cyclin-dependent kinase-2 as revealed by the molecular dynamics study on the complex CDK2 with the peptide substrate HHASPRK.通过对细胞周期蛋白依赖性激酶2(CDK2)与肽底物HHASPRK复合物的分子动力学研究揭示的CDK2抑制机制。
对与阿尔茨海默病病理学相关的蛋白激酶灵活性的研究。
Molecules. 2014 Jun 30;19(7):9134-59. doi: 10.3390/molecules19079134.
4
Molecular basis of differential selectivity of cyclobutyl-substituted imidazole inhibitors against CDKs: insights for rational drug design.环丁基取代咪唑抑制剂对 CDK 选择性差异的分子基础:对合理药物设计的启示。
PLoS One. 2013 Sep 13;8(9):e73836. doi: 10.1371/journal.pone.0073836. eCollection 2013.
5
Mechanism of CDK5 activation revealed by steered molecular dynamics simulations and energy calculations.定向分子动力学模拟和能量计算揭示的 CDK5 激活机制。
J Mol Model. 2010 Jun;16(6):1159-68. doi: 10.1007/s00894-009-0629-4. Epub 2009 Dec 15.
6
Explaining the inhibition of cyclin-dependent kinase 5 by peptides derived from p25 with molecular dynamics simulations and MM-PBSA.用分子动力学模拟和 MM-PBSA 解释源自 p25 的肽对周期蛋白依赖性激酶 5 的抑制作用。
J Mol Model. 2010 Jan;16(1):1-8. doi: 10.1007/s00894-009-0514-1. Epub 2009 May 23.
7
Regulation of Kalirin by Cdk5.细胞周期蛋白依赖性激酶5对卡里林的调控
J Cell Sci. 2008 Aug 1;121(Pt 15):2601-11. doi: 10.1242/jcs.016089. Epub 2008 Jul 15.
Protein Sci. 2005 Feb;14(2):445-51. doi: 10.1110/ps.04959705. Epub 2005 Jan 4.
4
Loop flexibility and solvent dynamics as determinants for the selective inhibition of cyclin-dependent kinase 4: comparative molecular dynamics simulation studies of CDK2 and CDK4.作为细胞周期蛋白依赖性激酶4选择性抑制决定因素的环柔韧性和溶剂动力学:细胞周期蛋白依赖性激酶2和细胞周期蛋白依赖性激酶4的比较分子动力学模拟研究
Chembiochem. 2004 Dec 3;5(12):1662-72. doi: 10.1002/cbic.200400214.
5
Activation and inhibition of cyclin-dependent kinase-2 by phosphorylation; a molecular dynamics study reveals the functional importance of the glycine-rich loop.通过磷酸化激活和抑制细胞周期蛋白依赖性激酶-2;一项分子动力学研究揭示了富含甘氨酸环的功能重要性。
Protein Sci. 2004 Jun;13(6):1449-57. doi: 10.1110/ps.03578504. Epub 2004 May 7.
6
Interaction of amiloride and one of its derivatives with Vpu from HIV-1: a molecular dynamics simulation.氨氯吡咪及其一种衍生物与HIV-1的Vpu之间的相互作用:分子动力学模拟
FEBS Lett. 2004 Apr 9;563(1-3):75-81. doi: 10.1016/S0014-5793(04)00251-0.
7
Cyclin-dependent kinase 5 in amyotrophic lateral sclerosis.肌萎缩侧索硬化症中的细胞周期蛋白依赖性激酶5
Neurosignals. 2003 Sep-Oct;12(4-5):215-20. doi: 10.1159/000074623.
8
Role of cdk5 in the pathogenesis of Alzheimer's disease.细胞周期蛋白依赖性激酶5在阿尔茨海默病发病机制中的作用。
Neurosignals. 2003 Sep-Oct;12(4-5):209-14. doi: 10.1159/000074622.
9
Cyclin-dependent kinase 5 is a mediator of dopaminergic neuron loss in a mouse model of Parkinson's disease.细胞周期蛋白依赖性激酶5是帕金森病小鼠模型中多巴胺能神经元损失的一个介质。
Proc Natl Acad Sci U S A. 2003 Nov 11;100(23):13650-5. doi: 10.1073/pnas.2232515100. Epub 2003 Oct 31.
10
A computational model of binding thermodynamics: the design of cyclin-dependent kinase 2 inhibitors.结合热力学的计算模型:细胞周期蛋白依赖性激酶2抑制剂的设计
J Med Chem. 2003 Jul 17;46(15):3314-25. doi: 10.1021/jm0205043.